Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration

Diabetes Research and Clinical Practice

Volumn 95, Issue 1, 2012, Pages 105-109

  Fu, Wen Jin ^a   Li, Bao Liang ^a   Wang, Shao Bo ^a   Chen, Mei Lian ^a   Deng, Ren Tang ^a   Ye, Chang Qin ^a   Liu, Liang ^a   Fang, Ai Juan ^a   Xiong, Shi Long ^b   Wen, Shu ^c   Tang, Hui Hua ^a   Chen, Zai Xing ^a   Huang, Zhi Hong ^a   Peng, Lan Fen ^a   Zheng, Lei ^b   Wang, Qian ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Glomerular hyperfiltration; Tubular markers; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN URINE LEVEL; SEX DIFFERENCE;

ACETYLGLUCOSAMINIDASE; ACUTE-PHASE PROTEINS; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TUBULES; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84355161652     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.09.031     Document Type: Article

References (27)

1. Krolewski M., Eggers P.W., Warram J.H. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study. Kidney Int 1996, 50:2041-2046.
2. Bojestig M., Arnqvist H.J., Hermansson G., Karlberg B.E., Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994, 330:15-18.
3. Rosolowsky E.T., Niewczas M.A., Ficociello L.H., Perkins B.A., Warram J.H., Krolewski A.S. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract 2008, 13(Suppl. 1):S46-S53.
4. Brenner B.M., Meyer T.W., Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982, 307:652-659.
5. Brenner B.M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983, 23:647-655.
6. von Eynatten M., Baumann M., Heemann U., Zdunek D., Hess G., Nawroth P.P., et al. Urinary L-FABP and anaemia: distinct roles of urinary markers in type diabetes. Eur J Clin Invest 2010, 40:95-102.
7. Nielsen S.E., Sugaya T., Tarnow L., Lajer M., Schjoedt K.J., Astrup A.S., et al. Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 2009, 32:1684-1688.
8. Damman K., Van Veldhuisen D.J., Navis G., Vaidya V.S., Smilde T.D., Westenbrink B.D., et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010, 96:1297-1302.
9. Fu W.J., Xiong S.L., Fang Y.G., Wen S., Chen M.L., Deng R.T., et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 2011, July 21 [Epub ahead of print].
10. Mishra J., Ma Q., Kelly C., Mitsnefes M., Mori K., Barasch J., et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006, 21:856-863.
11. Bazzi C., Petrini C., Rizza V., Arrigo G., Napodano P., Paparella M., et al. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002, 17:1890-1896.
12. Liangos O., Perianayagam M.C., Vaidya V.S., Han W.K., Wald R., Tighiouart H., et al. Urinary N-acetyl-beta-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:904-912.
13. Kang H.K., Kim D.K., Lee B.H., Om A.S., Hong J.H., Koh H.C., et al. Urinary N-acetyl-beta-d-glucosaminidase and malondialdehyde as a marker of renal damage in burned patients. J Korean Med Sci 2001, 16:598-602.
14. Waanders F., van Timmeren M.M., Stegeman C.A., Bakker S.J., van Goor H. Kidney injury molecule-1 in renal disease. J Pathol 2010, 220:7-16.
15. Macisaac R.J., Tsalamandris C., Thomas M.C., Premaratne E., Panagiotopoulos S., Smith T.J., et al. Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia 2006, 49:1686-1689.
16. Ficociello L.H., Perkins B.A., Roshan B., Weinberg J.M., Aschengrau A., Warram J.H., et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 2009, 32:889-893.
17. Magee G.M., Bilous R.W., Cardwell C.R., Hunter S.J., Kee F., Fogarty D.G. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009, 52:691-697.
18. Jerums G., Premaratne E., Panagiotopoulos S., Macisaac R.J. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010, 53:2093-2104.
19. Bruce R., Rutland M., Cundy T. Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diabetes Res Clin Pract 1994, 25:155-160.
20. Vedel P., Obel J., Nielsen F.S., Bang L.E., Svendsen T.L., Pedersen O.B., et al. Glomerular hyperfiltration in microalbuminuric NIDD patients. Diabetologia 1996, 39:1584-1589.
21. Keller C.K., Bergis K.H., Fliser D., Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 1996, 7:2627-2635.
22. Silviero S.P., Friedman R., Azevedo M.J., Canani L.H., Gross J.L. Five year prospective study of the glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 1996, 19:171-174.
23. Tan G.D., Lewis A.V., James T.J., Altmann P., Taylor R.P., Levy J.C. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 2002, 25:2004-2009.
24. Jin Y., Moriya T., Tanaka K., Matsubara M., Fujita Y. Glomerular hyperfiltration in non-proteinuric and non-hypertensive Japanese type 2 diabetic patients. Diabetes Res Clin Pract 2006, 71:264-271.
25. Devarajan P. Neutrophil gelatinase-associated lipocalin - an emerging troponin for kidney injury. Nephrol Dial Transplant 2008, 23:3737-3743.
26. Mocan Z., Erem C., Yildirim M., Telatar M., Deĝer O. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-d-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Diabetes Res 1994, 26:101-107.
27. Devarajan P. Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn 2008, 2:387-398.